DrugDosageComments
Chloroquine-sensitive malaria
  • Chloroquine (Aralen)

  • Begin 1 to 2 weeks before travel and continue for 4 weeks after leaving malaria-endemic area

  • Adults: 500 mg salt (equal to 300 mg base) once per week

  • Children: 8.3 mg salt (equal to 5 mg base) per kg per week, up to adult dosage

  • Used for prophylaxis in Mexico and Central America (west of the Panama Canal), and the island of Hispaniola (Haiti and the Dominican Republic)

  • In the United States, hydroxychloroquine may be better tolerated

  • Chloroquine may exacerbate psoriasis

  • Hydroxychloroquine (Plaquenil)

  • Begin 1 to 2 weeks before travel and continue for 4 weeks after leaving malaria-endemic area

  • Adults: 400 mg salt (equal to 310 mg base) once per week

  • Children: 6.5 mg salt (equal to 5 mg base) per kg per week, up to adult dosage

Chloroquine-resistant malaria
  • Atovaquone/proguanil (Malarone)

  • Begin 1 to 2 days before travel and continue for 1 week after leaving malaria-endemic area

  • Adults: 250 mg/100 mg per day

  • Children: 1 tablet = 62.5 mg/25 mg per day

  • < 5 kg: not recommended

  • 5 to 8 kg: one-half of a children's tablet daily

  • 9 to 10 kg: three-fourths of a children's tablet daily

  • 11 to 20 kg: 1 children's tablet daily

  • 21 to 30 kg: 2 children's tablets daily

  • 31 to 40 kg: 3 children's tablets daily

  • > 40 kg: 1 adult tablet daily

  • Useful in regions of mefloquine resistance

  • Contraindicated in patients with severe renal impairment (a creatinine clearance < 30 mL per minute per 1.73 m2 [0.50 mL per second per m2]); high cost makes this drug less desirable for longer trips

  • Avoid in pregnant women and mothers who are breastfeeding infants weighing < 11 lb (5 kg)

  • Should be taken with food or a milky drink

  • Doxycycline

  • Begin 1 to 2 days before travel and continue for 4 weeks after leaving malaria-endemic area

  • Adults: 100 mg once per day

  • Children: 2 mg per kg per day, up to the adult dosage

  • Useful in regions of mefloquine resistance

  • Contraindicated in children younger than 8 years, and in pregnant and lactating women

  • May cause nausea, photosensitivity, vaginal yeast infections, and esophageal ulceration

  • Mefloquine

  • Begin ≥ 2 weeks before travel and continue for 4 weeks after leaving malaria-endemic area

  • Adults: 250 mg salt (equal to 228 mg base) once per week

  • Children: ≤ 9 kg: 5 mg per kg (4.6 mg per kg base) once per week


  • > 9 to 19 kg: one-fourth of 250-mg tablet weekly

  • 20 to 30 kg: one-half of 250-mg tablet weekly

  • 31 to 45 kg: three-fourths of 250-mg tablet weekly

  • > 45 kg: 250 mg once per week

Contraindications include epilepsy, psychiatric conditions (including anxiety and depression), and cardiac conduction disorders; may be used in all trimesters of pregnancy
Short-term travel to areas with more than 90% Plasmodium vivax malaria (e.g., Central and South America)
  • Primaquine

  • Begin 1 to 2 days before travel and continue for 1 week after leaving malaria-endemic area

  • Adults: 52.6 mg salt (equal to 30 mg base) once per day

  • Children: 0.8 mg per kg salt (equal to 0.5 mg per kg base) once per day, up to adult dosage

  • Screen for G6PD deficiency before use; can be fatal if taken by patients who are G6PD negative

  • Contraindicated in pregnant women, and in breastfeeding mothers unless the infant has a documented normal G6PD level

  • Not commonly used relative to other prophylactic drugs